PLAY PODCASTS
Cases and Controversies in HIV: ARV-Associated Weight Gain
Episode 44

Cases and Controversies in HIV: ARV-Associated Weight Gain

Listen to José R. Arribas, MD; Andrew Carr, MBBS, MD, FRACP, FRCPA; and Lynora Saxinger, MD, FRCPC, CTropMed, discuss a patient case highlighting the concerns for ARV-associated weight gain with HIV treatment initiation.

Decera Clinical Education Infectious Disease Podcast · Andrew Carr MBBS MD FRACP FRCPA, José R. Arribas MD, Lynora Saxinger MD FRCPC CTropMed

April 23, 202116m 42s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Drs José R. Arribas, Andrew Carr, and Lynora Saxinger discuss weight gain concerns for a patient with initiating ART.

Presenters:

José R. Arribas, MD
Research Director, HIV and Infectious Diseases
Hospital La Paz IdiPAZ
Madrid, Spain

Andrew Carr, MBBS, MD, FRACP, FRCPA
Professor of Medicine
University of New South Wales
Director, HIV and Immunology Unit
St Vincent’s Hospital
Sydney, Australia

Lynora Saxinger, MD, FRCPC, CTropMed
Cochair, Scientific Advisory Group
Alberta COVID-19 Emergency
Coordination Centre
Associate Professor
Division of Infectious Diseases
Department of Medicine
University of Alberta
Edmonton, Alberta
Canada

Content based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.

Link to full program:
https://bit.ly/3xdgcTk


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

tenofovir dfdolutegravirdoravirinebicprotease inhibitorsias-usa guidelinesdtgart weight gaininitial arthiv treatment-naivedhhs guidelinesbic/ftc/taftenofovir alafenamideantiretroviral therapyintegrase inhibitorshiv weight gainhiv weight gaininstisinsti weight gaintdfarv-associated weight gainhiv single-tablet regimensralftc/tdfftc/tafdtg/3tctaffirst-line artarthiv